Allergan Aesthetics offers aesthetic products and services, including injectable treatments and medical devices. It is self-described as being part of AbbVie.

Allergan Aesthetics

RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.

RVL Pharmaceuticals plc

Medical Equipment Manufacturing

CoolSculpting

Pharmaceutical Manufacturing

BOTOX® Cosmetic (onabotulinumtoxinA)

Allergan Medical Institute

JUVÉDERM® Collection of Fillers

Allergan Aesthetics Plastic and Regenerative Medicine Portfolio

Natrelle Breast Implants

Allergan Aesthetics, an AbbVie Company | 80,150 followers on LinkedIn. At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more.

At Allergan Aesthetics™ we believe in the remarkable impact confidence can have on the lives, businesses, and careers of those we serve through our history of a company built on patient-care, education and support of our customers, and our commitment to putting the patients we serve first.

Michelle Hinds

GTM | Field and Seller Readiness | Product Marketing | Ex-Salesforce

Anni Schleicher

André Palombo

Digital Strategy | Growth Marketing | Paid Media | Empathetic Leader

Melody Frieda

Allergan Aesthetics, an AbbVie Company

With a lack of formal training programs in our industry, #AllerganMedicalInstitute has a responsibility to educate professionals on the use and safety of our products. In Rome, Italy, Djordje Stojic fronted the development of a new, state of the art AMI Center of Excellence, which has been in high demand since its opening. #EmpoweringConfidence #ConfidenceWithin #AllerganAesthetics

I was honored and inspired to participate in this year’s Golden Ticket competition, which exemplifies continued investment by Allergan Aesthetics, an AbbVie Company in early science and regenerative technologies to help define what’s next for the aesthetics industry.

Darin Messina

How do you find The Confidence Within? Each episode of this new series will feature an exemplary Allergan Aesthetics employee from around the world who pulled from their confidence to create something truly great. Watch Maria and her story about leading product launches and creating a “moment” in Colombia! #EmpoweringConfidence #ConfidenceWithin #AllerganAesthetics

Join us at the forefront of Aesthetics Ethics! With the help of medical aesthetics experts from around the globe, we aim to ignite conversations on the importance of ethics in every stage of aesthetic medicine. Visit https://lnkd.in/g3emScwM to download your copy of “Moving the Needle on Ethics.” #AllerganAesthetics

On this #ClinicalTrialsDay , I’m celebrating all who make clinical trials possible. At Allergan Aesthetics we recognize comprehensive clinical study programs are essential to delivering a broad pipeline in aesthetic medicine and we rely on scientific rigor and robust clinical trials to develop what’s next. Thank you to our investigators, trial participants, study sites, partners and dedicated clinical team around the world for all you do!

Who’s ready for The Aesthetic Meeting 2024 tomorrow!? We’re excited to see you all at the Vancouver Convention Center in BC, Canada. Be sure to check your event schedule and stop by Booth # 703! #AllerganAesthetics

Did you catch the Science of Aging symposia at #AMWC2024 ? Focused on topics of cellular rewiring to rewind aging, the program explored the latest early science and research insights in the field of aging.

I ROSI VIVANCOS x #DIRECTORASGENERALES I 🙋♀️ Rosi Vivancos , directora general de Allergan Aesthetics y miembro del Comité Promotor de Mujeres en Farma , forma parte de nuestras #directorasgenerales . 🌍 "Uno de los principales retos fue la experiencia internacional: estuve cinco años trabajando en París de lunes a jueves, volviendo a Madrid de jueves a domingo" 💫 Rosi, médico de profesión, ha hablado sobre cómo la experiencia internacional fue uno de sus mayores retos en su carrera profesional. Además, ha recalcado la importancia de saber cuál es el camino de carrera en las compañías y poner todos los medios para poder alcanzar posiciones más altas. ¡Quédate a ver la entrevista completa! 👀 ⤵ 📌 Descubre más sobre #directorasgenerales aquí https://lnkd.in/dK6vRhrw #mujeresenfarma #talentofemenino #networking #mentoring #women #pharma #farma #diversidad #diversity

Mujeres en Farma

That’s a wrap! Thank you to everyone who joined us on this journey to explore how we aim to champion individuality, drive innovation and lead with integrity. Here, we explored what it means to be a True Original in aesthetics, demonstrated the diversity of our growing portfolio, and how we can continue to shape the future of aesthetics. We introduced ‘Moving the Needle on Ethics,’ demonstrating our commitment to patient safety and high ethical standards. We celebrated a decade of empowering excellence in aesthetics with AMI. Can’t wait to see you next year! #AMWC #AMWC2024

Join our “Meet the Expert” sessions live from our booth (K2) at #AMWC , Monaco!

Metric
Company Name	Allergan Aesthetics	RVL Pharmaceuticals plc
Symbol		RVLP
MSH ID	COM:ALLERGANAESTHETICS	COM:RVLPHARMA
Market	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare
Industry	Cosmetics and Aesthetic Treatments	Biotechnology
Country	US	US
Stage
Employee Count		125
Website	allerganaesthetics.com	rvlpharma.com
LinkedIn	allergan-aesthetics	rvl-pharmaceuticals-inc
Founders

Metric
Market Cap		3.14M
Enterprise Value
Monthly Web Traffic	24.70K	1.19K
Web Traffic Growth	2.20	-0.82
Valuation
Raised Capital

Metric
Revenue		49.72M
Revenue (LTM)
Revenue (NTM)
Gross Profit		40.27M
EBITDA		-36.19M
Operating Income		-45.68M
Net Income		-51.69M
EPS		-0.58
Diluted EPS		-0.58
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.75
Operating Profit Margin		-1.56
EBITDA Margin		-0.73
Net Profit Margin		-1.85
Return on Equity		-1.55
Return on Assets		-0.80
Return on Capital Employed		-3.38

ALLE

COM:ALLERGANAESTHETICS

Allergan Aesthetics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		-0.04
P/B Ratio		0.17
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		0.09
EV Multiple		0.99

Metric
Days Sales Outstanding		19.10
Days Payables Outstanding		98.98
Days Inventory Outstanding		53.05
Operating Cycle		72.15
Cash Conversion Cycle		-26.83
Asset Turnover		0.43

Metric
Operating Cash Flow		-37.81M
Free Cash Flow		-38.56M
Cash Flow to Debt		-0.76
Operating Cash Flow/Sales		-1.20
Free Cash Flow Yield		-15.11

Metric
Cash & Equivalents		44.54M
Accounts Receivable		-898K
Inventory		784K
Goodwill		55.85M
Debt to Capitalization		0.78
Debt to Assets		0.68
Current Ratio		0.38
Quick Ratio		0.31

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.06
R&D to Revenue		0.08
SG&A to Revenue